Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
paper
Cited
Public
Unavailable
- Authors
- Huang, Jiansheng; Jia, Yuzhi; Fu, Tao; Viswakarma, Navin; Bai, Liang; Rao, M Sambasiva; Zhu, Yijun; Borensztajn, Jayme; Reddy, Janardan K
- Year
- 2012
- Journal
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- PMID
- 22009939
- DOI
- 10.1096/fj.11-194019
- PMCID
- PMC3290446
Obesity, a major health concern, results from an imbalance between energy intake and expenditure. Leptin-deficient ob/ob mice are paradigmatic of obesity, resulting from excess energy intake and storage. Mice lacking acyl-CoA oxidase 1 (Acox1), the first enzyme of the peroxisomal fatty acid β-oxidation system, are characterized by increased energy expenditure and a lean body phenotype caused by sustained activation of peroxisome proliferator-activated receptor α (PPARα) by endogenous ligands in liver that remain unmetabolized in the absence of Acox1. We generated ob/ob mice deficient in Acox1 (Acox1(-/-)) to determine how the activation of PPARα by endogenous ligands might affect the obesity of ob/ob mice. In contrast to Acox1(-/-) (14.3±1.2 g at 6 mo) and the Acox1-deficient (ob/ob) double-mutant mice (23.8±4.6 g at 6 mo), the ob/ob mice are severely obese (54.3±3.2 g at 6 mo) and had significantly more (P<0.01) epididymal fat content. The resistance of Acox1(-/-)/ob/ob mice to obesity is due to increased PPARα-mediated up-regulation of genes involved in fatty acid oxidation in liver. Activation of PPARα in Acox1-deficient ob/ob mice also reduces serum glucose and insulin (P<0.05) and improves glucose tolerance and insulin sensitivity. Further, PPARα activation reduces hepatic steatosis and increases hepatocellular regenerative response in Acox1(-/-)/ob/ob mice at a more accelerated pace than in mice lacking only Acox1. However, Acox1(-/-)/ob/ob mice manifest hepatic endoplasmic reticulum (ER) stress and also develop hepatocellular carcinomas (8 of 8 mice) similar to those observed in Acox1(-/-) mice (10 of 10 mice), but unlike in ob/ob (0 of 14 mice) and OB/OB (0 of 6 mice) mice, suggesting that superimposed ER stress and PPARα activation contribute to carcinogenesis in a fatty liver. Finally, absence of Acox1 in ob/ob mice can impart resistance to high-fat diet (60% fat)-induced obesity, and their liver had significantly (P<0.01) more cell proliferation. These studies with Acox1(-/-)/ob/ob mice indicate that sustained activation of lipid-sensing nuclear receptor PPARα attenuates obesity and restores glucose homeostasis by ameliorating insulin resistance but increases the risk for liver cancer development, in part related to excess energy combustion.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2019 | 29568101 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Targeting peroxisomal fatty acid β-oxidation lowers fasting glucose by suppressing gluconeogenesis. | Zhang W et al. | — | 2026 | → |
| The emerging role of FGF21 in alcohol consumption and dependence: mechanisms and therapeutic prospects. | Kaur S et al. | — | 2026 | → |
| A metabolomics and proteomics-based study on the metabolic effects of arecoline on the liver. | Cao Z et al. | — | 2025 | → |
| B-Cell Receptor-Associated Protein 31 Deficiency Aggravates Ethanol-Induced Liver Steatosis and Liver Injury via Attenuating Fatty Acid Oxidation and Glycogen Synthesis. | Yu S et al. | — | 2025 | → |
| Hepatic FGF21 Deletion Improves Glucose Metabolism, Alters Lipogenic and <i>Chrna4</i> Gene Expression, and Enhances Telomere Maintenance in Aged Female Mice. | Torres-Oteros D et al. | — | 2025 | → |
| Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice. | Ivashkevich D et al. | — | 2025 | → |
| Transcriptomics and proteomics characterizing the antioxidant mechanisms of semaglutide in diabetic mice with cognitive impairment. | Yang Y et al. | — | 2025 | → |
| Augmenter of liver regeneration knockout aggravates tubular ferroptosis and macrophage activation by regulating carnitine palmitoyltransferase-1A-induced lipid metabolism in diabetic nephropathy. | Zhang Y et al. | — | 2024 | → |
| Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD). | Singh S et al. | — | 2024 | → |
| Hepatocyte-Specific PEX16 Abrogation in Mice Leads to Hepatocyte Proliferation, Alteration of Hepatic Lipid Metabolism, and Resistance to High-Fat Diet (HFD)-Induced Hepatic Steatosis and Obesity. | Chen X et al. | — | 2024 | → |
| Long noncoding RNA UCA1 inhibits epirubicin-induced apoptosis by activating PPARα-mediated lipid metabolism. | Sun S et al. | — | 2024 | → |
| Mapping novel QTL and fine mapping of previously identified QTL associated with glucose tolerance using the collaborative cross mice. | Abu-Toamih-Atamni HJ et al. | — | 2024 | → |
| Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1. | Shang Z et al. | — | 2024 | → |
| SWATH-MS reveals that bisphenol A and its analogs regulate pathways leading to disruption in insulin signaling and fatty acid metabolism. | Kulsange SE et al. | — | 2024 | → |
| The natural compounds, Magnolol or Honokiol, promote adipose tissue browning and resist obesity through modulating PPARα/γ activity. | Chu Y et al. | — | 2024 | → |
| Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets. | Dey AD et al. | — | 2024 | → |
| Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy. | Zhang CY et al. | — | 2023 | → |
| Hepatic Krüppel-like factor 14 regulates lipid metabolism in nonalcoholic steatohepatitis mice. | Chen X et al. | — | 2023 | → |
| Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. | Pal SC et al. | — | 2023 | → |
| Mapping Novel Glucose tolerance specific QTL in the Collaborative Cross mice | Abu-Toamih-Atamni HJ et al. | — | 2023 | — |
| Mouse Models to Study Peroxisomal Functions and Disorders: Overview, Caveats, and Recommendations. | Kocherlakota S et al. | — | 2023 | → |
| Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice. | Yao H et al. | — | 2023 | → |
| ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. | Kong D et al. | — | 2022 | → |
| Bailing capsule (<i>Cordyceps sinensis</i>) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats. | Zhang Q et al. | — | 2022 | → |
| Cancer-Related Cachexia: The Vicious Circle between Inflammatory Cytokines, Skeletal Muscle, Lipid Metabolism and the Possible Role of Physical Training. | Mangano GD et al. | — | 2022 | → |
| Conjugated linoleic acid regulates adipocyte fatty acid binding protein expression <i>via</i> peroxisome proliferator-activated receptor α signaling pathway and increases intramuscular fat content. | Chen J et al. | — | 2022 | → |
| Crosstalk between CYP2E1 and PPAR<i>α</i> substrates and agonists modulate adipose browning and obesity. | Zhang Y et al. | — | 2022 | → |
| <i>Lactobacillus plantarum</i> ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota. | Cao F et al. | — | 2022 | → |
| Lactobacillus rhamnosus Strain LRH05 Intervention Ameliorated Body Weight Gain and Adipose Inflammation via Modulating the Gut Microbiota in High-Fat Diet-Induced Obese Mice. | Chen YT et al. | — | 2022 | → |
| Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. | Guo X et al. | — | 2022 | → |
| Obesity downregulates lipid metabolism genes in first trimester placenta. | Rasool A et al. | — | 2022 | → |
| Role of acyl-coenzyme A oxidase 1 (ACOX1) on palmitate-induced inflammation and ROS production of macrophages in large yellow croaker (Larimichthys crocea). | Kong A et al. | — | 2022 | → |
| Suppression of Anti-Inflammatory Mediators in Metabolic Disease May Be Driven by Overwhelming Pro-Inflammatory Drivers. | Sajid S et al. | — | 2022 | → |
| The Potential Role of PPARs in the Fetal Origins of Adult Disease. | Guo J et al. | — | 2022 | → |
| Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms. | Meng X et al. | — | 2022 | → |
| Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy. | Chen N et al. | — | 2021 | → |
| Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. | Sun N et al. | — | 2021 | → |
| Laminin-α4 Is Upregulated in Both Human and Murine Models of Obesity. | Goddi A et al. | — | 2021 | → |
| <sup>1</sup>H NMR Metabolomics and Full-Length RNA-Seq Reveal Effects of Acylated and Nonacylated Anthocyanins on Hepatic Metabolites and Gene Expression in Zucker Diabetic Fatty Rats. | Chen K et al. | — | 2021 | → |
| Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate. | Hinds TD et al. | — | 2020 | → |
| Comparison of transcriptomic changes between zebrafish and mice upon high fat diet reveals evolutionary convergence in lipid metabolism. | Ka J et al. | — | 2020 | → |
| Dietary Silk Peptide Prevents High-Fat Diet-Induced Obesity and Promotes Adipose Browning by Activating AMP-Activated Protein Kinase in Mice. | Lee K et al. | — | 2020 | → |
| High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. | Chen X et al. | — | 2020 | → |
| Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. | Zhai T et al. | — | 2020 | → |
| <i>FASN</i>-Mediated Lipid Metabolism Regulates Goose Granulosa Cells Apoptosis and Steroidogenesis. | Chen X et al. | — | 2020 | → |
| Impaired peroxisomal fat oxidation induces hepatic lipid accumulation and oxidative damage in Nile tilapia. | Liu Y et al. | — | 2020 | → |
| PPARs and Microbiota in Skeletal Muscle Health and Wasting. | Manickam R et al. | — | 2020 | → |
| A microglial cell model for acyl-CoA oxidase 1 deficiency. | Raas Q et al. | — | 2019 | → |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | — | 2019 | → |
| Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway. | Bian Y et al. | — | 2019 | → |
| Fermented <i>Cordyceps militaris</i> Extract Ameliorates Hepatosteatosis via Activation of Fatty Acid Oxidation. | Tran NKS et al. | — | 2019 | → |
| Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice. | Yao L et al. | — | 2019 | → |
| Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response. | Rutkowski DT | — | 2019 | → |
| LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression. | Zhang T et al. | — | 2019 | → |
| Metallothionein 3 Controls the Phenotype and Metabolic Programming of Alternatively Activated Macrophages. | Chowdhury D et al. | — | 2019 | → |
| A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet. | Zhang T et al. | — | 2018 | → |
| Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study. | Oscarsson J et al. | — | 2018 | → |
| Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. | Moreno-Fernandez ME et al. | — | 2018 | → |
| PPAR Agonists and Metabolic Syndrome: An Established Role? | Botta M et al. | — | 2018 | → |
| Screening of biomarkers for liver adenoma in low-dose-rate γ-ray-irradiated mice. | Sugihara T et al. | — | 2018 | → |
| MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. | Wu H et al. | — | 2017 | → |
| mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis. | Hallowell RW et al. | — | 2017 | → |
| Proteomic analysis of physiological function response to hot summer in liver from lactating dairy cows. | Wang Q et al. | — | 2017 | → |
| Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet. | Zeng J et al. | — | 2017 | → |
| The Interplay of Genetics and Environmental Factors in the Development of Obesity. | Sheikh AB et al. | — | 2017 | → |
| Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? | Hinds TD et al. | — | 2016 | → |
| Expression of candidate genes associated with obesity in peripheral white blood cells of Mexican children. | Ulloa-Martínez M et al. | — | 2016 | → |
| Hepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase <i>in vivo</i> and <i>in vitro</i>. | Chen WM et al. | — | 2016 | → |
| SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300. | Zhang ZN et al. | — | 2016 | → |
| Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress. | Jiang Y et al. | — | 2015 | → |
| Mitochondrial sirtuins: emerging roles in metabolic regulations, energy homeostasis and diseases. | Parihar P et al. | — | 2015 | → |
| Molecular insights into the mechanisms of liver-associated diseases in early-lactating dairy cows: hypothetical role of endoplasmic reticulum stress. | Ringseis R et al. | — | 2015 | → |
| PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. | Gao Q et al. | — | 2015 | → |
| Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. | Prabhakar P et al. | — | 2015 | → |
| Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice. | Moon J et al. | — | 2014 | → |
| Energy metabolism in the liver. | Rui L | — | 2014 | → |
| Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats. | Ezrokhi M et al. | — | 2014 | → |
| Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis. | Misra P et al. | — | 2014 | → |
| Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. | Lu HJ et al. | — | 2014 | → |
| The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet. | Chang CJ et al. | — | 2014 | → |
| Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet. | Zhang X et al. | — | 2013 | → |
| Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in mice. | Ford NA et al. | — | 2013 | → |
| Grape seed proanthocyanidin rescues rats from steatosis: a comparative and combination study with metformin. | Yogalakshmi B et al. | — | 2013 | → |
| Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis. | Basseri S et al. | — | 2013 | → |
| NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytes. | Pessentheiner AR et al. | — | 2013 | → |
| Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways. | Zhang H et al. | — | 2013 | → |
| Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis. | Misra P et al. | — | 2013 | → |
| PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. | He J et al. | — | 2013 | → |
| Stressed Liver and Muscle Call on Adipocytes with FGF21. | Luo Y et al. | — | 2013 | → |
| Tert-butylhydroquinone reduces lipid accumulation in C57BL/6 mice with lower body weight gain. | Nam KW et al. | — | 2013 | → |
| Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet. | Tzeng TF et al. | — | 2013 | → |
| Effect of intrauterine growth retardation on liver and long-term metabolic risk. | Cianfarani S et al. | — | 2012 | → |
| Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. | Kawai D et al. | — | 2012 | → |
| Inhibition of fatty acid oxidation enhances oxidative protein folding and protects hepatocytes from endoplasmic reticulum stress. | Tyra HM et al. | — | 2012 | → |
| Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism. | Tryndyak V et al. | — | 2012 | → |
| Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. | Newman JC et al. | — | 2012 | → |